Medical Journals

Induction of Intrahepatic Cholangiocellular Carcinoma by Liver-specific Disruption of Smad4 and Pten in Mice.

Authors:
  • Xu Xiaoling
  • Kobayashi Shogo
  • Qiao Wenhui
  • Li Cuiling
  • Xiao Cuiying
  • Radaeva Svetlana
  • Stiles Bangyan
  • Wang Rui-Hong
  • Ohara Nobuya
  • Yoshino Tadashi
  • LeRoith Derek
  • Torbenson Michael S
  • Gores Gregory J
  • Wu Hong
  • Gao Bin
  • Deng Chu-Xia

From: Genetics of Development and Disease Branch, NIDDK, NIH, Bethesda, Maryland 20892, USA.

The Journal of clinical investigation

  • Publish Date: Jul 2006
  • ISSN: 0021-9738
  • Volume: 116
  • Issue: 7
  • Pages: 1843-52
  • Medium: Print
  • Language: English
  • Citation (JAMA): Xu Xiaoling, Kobayashi Shogo, Qiao Wenhui, et al. Induction of Intrahepatic Cholangiocellular Carcinoma by Liver-specific Disruption of Smad4 and Pten in Mice.. J. Clin. Invest. Jul 2006;116:1843-52

Abstract

Cholangiocellular carcinoma (CC), the second most common primary liver cancer, is associated with a poor prognosis. It has been shown that CCs harbor alterations of a number of tumor-suppressor genes and oncogenes, yet key regulators for tumorigenesis remain unknown. Here we have generated a mouse model that develops CC with high penetrance using liver-specific targeted disruption of tumor suppressors SMAD4 and PTEN. In the absence of SMAD4 and PTEN, hyperplastic foci emerge exclusively from bile ducts of mutant mice at 2 months of age and continue to grow, leading to tumor formation in all animals at 4-7 months of age. We show that CC formation follows a multistep progression of histopathological changes that are associated with significant alterations, including increased levels of phosphorylated AKT, FOXO1, GSK-3beta, mTOR, and ERK and increased nuclear levels of cyclin D1. We further demonstrate that SMAD4 and PTEN regulate each other through a novel feedback mechanism to maintain an expression balance and synergistically repress CC formation. Finally, our analysis of human CC detected PTEN inactivation in a majority of p-AKT-positive CCs, while about half also lost SMAD4 expression. These findings elucidate the relationship between SMAD4 and PTEN and extend our understanding of CC formation.

Mesh Headings (Keywords): Animals, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Cells, Cultured, Cholangiocarcinoma, Disease Models, Animal, Enzyme Inhibitors, Forkhead Transcription Factors, Gene Expression Regulation, Genotype, Humans, Liver, Mice, Mice, Knockout, PTEN Phosphohydrolase, Protein Kinases, Proto-Oncogene Proteins c-akt, Smad4 Protein


Check for Full Text / PubMed Unique Identifier (PMID): 16767220


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.